CAELUM BIOSCIENCES Trademark

Trademark Overview

On Thursday, January 12, 2017, a trademark application was filed for CAELUM BIOSCIENCES with the United States Patent and Trademark Office. The USPTO has given the CAELUM BIOSCIENCES trademark a serial number of 87299029. The federal status of this trademark filing is REGISTERED as of Tuesday, March 23, 2021. This trademark is owned by Caelum Biosciences, Inc.. The CAELUM BIOSCIENCES trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of amyloidosis and diseases where amyloid deposits are present; Pharmaceutical preparations for human use for the treatment and prevention of progressive organ disease and failure; Pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of amyloidosis and diseases where amyloid deposits are present; Pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of progressive organ disease and failure
caelum biosciences

General Information

Serial Number87299029
Word MarkCAELUM BIOSCIENCES
Filing DateThursday, January 12, 2017
Status700 - REGISTERED
Status DateTuesday, March 23, 2021
Registration Number6301542
Registration DateTuesday, March 23, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 5, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of amyloidosis and diseases where amyloid deposits are present; Pharmaceutical preparations for human use for the treatment and prevention of progressive organ disease and failure; Pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of amyloidosis and diseases where amyloid deposits are present; Pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of progressive organ disease and failure
Disclaimer with Predetermined Text"BIOSCIENCES"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 19, 2017
Primary Code005
First Use Anywhere DateTuesday, March 24, 2020
First Use In Commerce DateTuesday, March 24, 2020

Trademark Owner History

Party NameCaelum Biosciences, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10014
Party NameCaelum Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10014
Party NameCaelum Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10014

Trademark Events

Event DateEvent Description
Thursday, April 11, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 11, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 11, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 26, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 26, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, October 26, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 26, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 23, 2021REGISTERED-PRINCIPAL REGISTER
Friday, February 19, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, February 18, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 2, 2021STATEMENT OF USE PROCESSING COMPLETE
Friday, January 29, 2021USE AMENDMENT FILED
Friday, January 29, 2021TEAS STATEMENT OF USE RECEIVED
Thursday, January 28, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 28, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 28, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 21, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 20, 2020SOU EXTENSION 5 GRANTED
Thursday, July 16, 2020SOU EXTENSION 5 FILED
Thursday, July 16, 2020SOU TEAS EXTENSION RECEIVED
Thursday, February 27, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 27, 2020CORRECTED NOA E-MAILED
Wednesday, February 26, 2020SOU EXTENSION 4 GRANTED
Monday, January 27, 2020SOU EXTENSION 4 FILED
Wednesday, February 26, 2020DIVISIONAL PROCESSING COMPLETE
Monday, January 27, 2020DIVISIONAL REQUEST RECEIVED
Wednesday, February 26, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 27, 2020TEAS REQUEST TO DIVIDE RECEIVED
Monday, January 27, 2020SOU TEAS EXTENSION RECEIVED
Thursday, June 27, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 25, 2019SOU EXTENSION 3 GRANTED
Tuesday, June 25, 2019SOU EXTENSION 3 FILED
Tuesday, June 25, 2019SOU TEAS EXTENSION RECEIVED
Wednesday, January 9, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 7, 2019SOU EXTENSION 2 GRANTED
Monday, January 7, 2019SOU EXTENSION 2 FILED
Monday, January 7, 2019SOU TEAS EXTENSION RECEIVED
Saturday, July 21, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 19, 2018SOU EXTENSION 1 GRANTED
Thursday, July 19, 2018SOU EXTENSION 1 FILED
Thursday, July 19, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, January 30, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 5, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 5, 2017PUBLISHED FOR OPPOSITION
Wednesday, November 15, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 26, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 25, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 24, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 24, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 28, 2017COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Friday, April 28, 2017ASSIGNED TO LIE
Friday, April 28, 2017NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Friday, April 28, 2017EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Friday, April 28, 2017EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Thursday, April 6, 2017ASSIGNED TO EXAMINER
Thursday, January 19, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 16, 2017NEW APPLICATION ENTERED

Related Keywords

biosciences caelum pharmaceutical treatment human preparations organ disease antibodies progressive namely failure